CCL2 and breast angiosarcoma: Based on ROC curve analysis as displayed in Fig 6A, among 27 systemic cytokines, 4 (IL-8, IP-10, MCP-1, and PDGF) yielded an AUC of more than 0.90, thereby establishing their potential as more sensitive and specific biomarkers for differentiating BA patients from healthy controls than others.